United States Healthcare Equipment & Supplies

Femasys Inc (FEMY)

Track

Track

Femasys Inc. experienced notable insider activity recently, with five executives purchasing shares totaling $134,000 on August 7, 2026. This buying occurred despite a 69.2% decline in stock price over the past quarter. These acquisitions follow a positive earnings report where the company exceeded expectations by 21.07%. No selling activity was recorded during this period.
Ticker: FEMY Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Femasys Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Mifek Jeffrey Gerald Chief Clinical-Medical Affairs Officer
Transaction date
Purchase
Price
232.10
Quantity 14,149 +35.2%
Value US$1,827,196
Sipos Jeremy Alexander Chief Technology Officer Officer
Transaction date
Purchase
Price
183.26
Quantity 76,912 +38.6%
Value US$1,994,596
Canning John Charles Chief Operating Officer Officer
Transaction date
Purchase
Price
307.52
Quantity 39,766 -48.5%
Value US$4,575,315
2.4
Elefant Dov Chief Financial Officer Officer
Transaction date
Purchase
Price
3.20
Quantity 1,000 +inf%
Value US$100,000
Lee-Sepsick Kathy Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.20
Quantity 1,000 +inf%
Value US$100,000
0.9
Dyett John Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.95
Quantity 1,000 +0.9%
Value US$9,950
0.9
Dyett John Non-Executive Director Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 40,000 +400.0%
Value US$520,000
Adams John Q JR Non-Executive Director
Transaction date
Purchase
Price
13.00
Quantity 40,000 +inf%
Value US$520,000
Uzialko Edward R Non-Executive Director
Transaction date
Purchase
Price
13.00
Quantity 100,000 +359.9%
Value US$1,300,000
0.9
Dyett John Non-Executive Director Large shareholder
Transaction date
Purchase
Price
12.88
Quantity 10,000 +inf%
Value US$128,800
0.9
Dyett John Non-Executive Director Large shareholder
Transaction date
Purchase
Price
13.18
Quantity 2,500 +inf%
Value US$32,950
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-11 2026-08-07 B Purchase
Mifek Jeffrey Gerald

Chief Clinical-Medical Affairs

Officer
14,149 +35.2%
232.10
US$1,827,196 		14,149 +35.2% 232.10 US$1,827,196
2026-08-11 2026-08-07 B Purchase
Sipos Jeremy Alexander

Chief Technology Officer

Officer
76,912 +38.6%
183.26
US$1,994,596 		76,912 +38.6% 183.26 US$1,994,596
2026-08-11 2026-08-07 B Purchase
Canning John Charles

Chief Operating Officer

Officer
39,766 -48.5%
307.52
US$4,575,315 		39,766 -48.5% 307.52 US$4,575,315
2026-08-11 2026-08-07 B Purchase
2.4
Elefant Dov

Chief Financial Officer

Officer
1,000 +inf%
3.20
US$100,000 		1,000 +inf% 3.20 US$100,000
2026-08-11 2026-08-07 B Purchase
Lee-Sepsick Kathy

Chief Executive Officer

Executive Director
1,000 +inf%
3.20
US$100,000 		1,000 +inf% 3.20 US$100,000
2021-06-24 2021-06-23 B Purchase
0.9
Dyett John
Non-Executive Director Large shareholder
1,000 +0.9%
9.95
US$9,950 		1,000 +0.9% 9.95 US$9,950
2021-06-24 2021-06-22 B Purchase
0.9
Dyett John
Non-Executive Director Large shareholder
40,000 +400.0%
13.00
US$520,000 		40,000 +400.0% 13.00 US$520,000
2021-06-24 2021-06-22 B Purchase
Adams John Q JR
Non-Executive Director
40,000 +inf%
13.00
US$520,000 		40,000 +inf% 13.00 US$520,000
2021-06-24 2021-06-22 B Purchase
Uzialko Edward R
Non-Executive Director
100,000 +359.9%
13.00
US$1,300,000 		100,000 +359.9% 13.00 US$1,300,000
2021-06-24 2021-06-18 B Purchase
0.9
Dyett John
Non-Executive Director Large shareholder
10,000 +inf%
12.88
US$128,800 		10,000 +inf% 12.88 US$128,800
2021-06-24 2021-06-18 B Purchase
0.9
Dyett John
Non-Executive Director Large shareholder
2,500 +inf%
13.18
US$32,950 		2,500 +inf% 13.18 US$32,950
Explore more

More insider trading research around Femasys Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America